Financial Ratios China Isotope & Radiation Corporation
Stocks
1763
CNE1000031F4
Medical Equipment, Supplies & Distribution
|
Market Closed -
Hong Kong S.E.
04:08:07 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 16.58 HKD | -0.12% |
|
-0.12% | -17.92% |
| Fiscal Period: December | 2016 (CNY) | 2017 (CNY) | 2018 (CNY) | 2019 (CNY) | 2020 (CNY) | 2021 (CNY) | 2022 (CNY) | 2023 (CNY) | 2024 (CNY) | 2025 (CNY) |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.72 | 4.93 | 3.75 | 4.83 | 4.18 | |||||
Return on Total Capital | 7.06 | 7.62 | 5.73 | 7.05 | 6.01 | |||||
Return On Equity % | 11.67 | 11.99 | 11.29 | 11.82 | 8.37 | |||||
Return on Common Equity | 8.32 | 9.06 | 8.1 | 8.39 | 6.4 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 63.03 | 57.18 | 52.48 | 48.62 | 50.39 | |||||
SG&A Margin | 45.11 | 38.45 | 36.26 | 30.75 | 32.42 | |||||
EBITDA Margin % | 17.52 | 17.15 | 14.66 | 16.97 | 17.22 | |||||
EBITA Margin % | 14.66 | 14.35 | 11.48 | 14.4 | 14.39 | |||||
EBIT Margin % | 14.44 | 14.21 | 11.3 | 14.26 | 14.18 | |||||
Income From Continuing Operations Margin % | 13.08 | 12.28 | 11.7 | 11.61 | 9.25 | |||||
Net Income Margin % | 6.53 | 6.37 | 5.59 | 5.37 | 4.56 | |||||
Net Avail. For Common Margin % | 6.53 | 6.37 | 5.59 | 5.37 | 4.56 | |||||
Normalized Net Income Margin | 3.15 | 3.47 | 1.09 | 2.54 | 3.97 | |||||
Levered Free Cash Flow Margin | 3.3 | 2.55 | -12.13 | -14.59 | 1.76 | |||||
Unlevered Free Cash Flow Margin | 3.72 | 2.89 | -11.8 | -14.2 | 2.32 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.52 | 0.55 | 0.53 | 0.54 | 0.47 | |||||
Fixed Assets Turnover | 2.18 | 2.3 | 2.03 | 1.91 | 1.6 | |||||
Receivables Turnover (Average Receivables) | 1.97 | 1.93 | 1.79 | 1.71 | 1.46 | |||||
Inventory Turnover (Average Inventory) | 2.37 | 2.89 | 3.05 | 3.63 | 2.8 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.68 | 1.88 | 1.93 | 1.78 | 1.76 | |||||
Quick Ratio | 1.43 | 1.64 | 1.63 | 1.54 | 1.43 | |||||
Operating Cash Flow to Current Liabilities | 0.2 | 0.22 | 0.02 | 0.03 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 185.17 | 189.42 | 204.06 | 214.46 | 250.62 | |||||
Days Outstanding Inventory (Average Inventory) | 154.33 | 126.13 | 119.69 | 100.88 | 130.16 | |||||
Average Days Payable Outstanding | 46.65 | 57.08 | 60.35 | 69.52 | 66.86 | |||||
Cash Conversion Cycle (Average Days) | 292.85 | 258.47 | 263.39 | 245.83 | 313.92 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 14.2 | 13.5 | 23.83 | 33.21 | 33.67 | |||||
Total Debt / Total Capital | 12.44 | 11.9 | 19.25 | 24.93 | 25.19 | |||||
LT Debt/Equity | 3.07 | 12.79 | 20.79 | 20.73 | 22.32 | |||||
Long-Term Debt / Total Capital | 2.69 | 11.27 | 16.79 | 15.56 | 16.69 | |||||
Total Liabilities / Total Assets | 42.42 | 43.92 | 45.88 | 47.56 | 48.25 | |||||
EBIT / Interest Expense | 21.82 | 26.7 | 21.53 | 22.88 | 15.91 | |||||
EBITDA / Interest Expense | 27.43 | 33.21 | 28.85 | 27.86 | 19.89 | |||||
(EBITDA - Capex) / Interest Expense | 14.87 | 16.89 | 3.08 | 6 | 11.04 | |||||
Total Debt / EBITDA | 0.92 | 0.81 | 1.69 | 1.96 | 2.15 | |||||
Net Debt / EBITDA | -2.07 | -1.9 | -1.23 | -0.08 | 0.09 | |||||
Total Debt / (EBITDA - Capex) | 1.69 | 1.6 | 15.87 | 9.08 | 3.87 | |||||
Net Debt / (EBITDA - Capex) | -3.82 | -3.73 | -11.56 | -0.38 | 0.17 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 20.34 | 19.49 | 7.82 | 14.16 | -5.11 | |||||
Gross Profit, 1 Yr. Growth % | 23.93 | 8.41 | -1.01 | 5.76 | -1.66 | |||||
EBITDA, 1 Yr. Growth % | 25.65 | 16.95 | -8.01 | 32.15 | -3.74 | |||||
EBITA, 1 Yr. Growth % | 26.89 | 16.92 | -13.77 | 43.26 | -5.23 | |||||
EBIT, 1 Yr. Growth % | 27.96 | 17.61 | -14.31 | 44.05 | -5.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 41.54 | 12.11 | 2.77 | 13.32 | -24.44 | |||||
Net Income, 1 Yr. Growth % | 57.2 | 16.64 | -5.43 | 9.62 | -19.48 | |||||
Normalized Net Income, 1 Yr. Growth % | 45.45 | 31.49 | -66.06 | 166.06 | 48.1 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 57.2 | 16.64 | -5.43 | 9.62 | -19.48 | |||||
Accounts Receivable, 1 Yr. Growth % | 20.35 | 23.79 | 10.61 | 27.84 | -1.83 | |||||
Inventory, 1 Yr. Growth % | 28.46 | 1.11 | 25.83 | -13.78 | 56.04 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 13.7 | 12.25 | 22.5 | 20.19 | 7.31 | |||||
Total Assets, 1 Yr. Growth % | 14.03 | 11.57 | 11.89 | 11.94 | 6.43 | |||||
Tangible Book Value, 1 Yr. Growth % | 7.56 | 7.41 | 2.87 | 4.63 | 2.18 | |||||
Common Equity, 1 Yr. Growth % | 7.4 | 6.84 | 5.03 | 6.65 | 4.42 | |||||
Cash From Operations, 1 Yr. Growth % | 172.11 | 8.6 | -90.16 | 67.71 | 277.83 | |||||
Capital Expenditures, 1 Yr. Growth % | 4.34 | 24.85 | 55.73 | 14.99 | -45.09 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -164.17 | -7.62 | -668.6 | 37.29 | -111.47 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -178.35 | -7.2 | -581.65 | 37.34 | -115.51 | |||||
Dividend Per Share, 1 Yr. Growth % | 109.6 | 16.62 | -28.95 | 21.81 | -19.48 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 13.56 | 19.92 | 13.58 | 10.95 | 4.08 | |||||
Gross Profit, 2 Yr. CAGR % | 7.04 | 15.91 | 3.64 | 2.32 | 1.98 | |||||
EBITDA, 2 Yr. CAGR % | 8.18 | 21.22 | 3.89 | 10.25 | 12.79 | |||||
EBITA, 2 Yr. CAGR % | 5.74 | 21.8 | 0.48 | 11.15 | 16.52 | |||||
EBIT, 2 Yr. CAGR % | 5.3 | 22.67 | 0.46 | 11.1 | 16.6 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 3.78 | 25.97 | 7.39 | 7.92 | -7.47 | |||||
Net Income, 2 Yr. CAGR % | 1.02 | 35.41 | 5.11 | 1.82 | -6.05 | |||||
Normalized Net Income, 2 Yr. CAGR % | -0.42 | 38.3 | -33.17 | -4.97 | 98.51 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 1.02 | 35.41 | 5.11 | 1.82 | -6.05 | |||||
Accounts Receivable, 2 Yr. CAGR % | 14.15 | 22.06 | 16.91 | 18.91 | 12.02 | |||||
Inventory, 2 Yr. CAGR % | 29.17 | 13.97 | 12.87 | 4.16 | 15.99 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 12.46 | 12.97 | 19.71 | 21.34 | 13.57 | |||||
Total Assets, 2 Yr. CAGR % | 8.83 | 12.79 | 12.23 | 11.92 | 9.15 | |||||
Tangible Book Value, 2 Yr. CAGR % | 5.03 | 7.49 | 5.16 | 3.75 | 3.4 | |||||
Common Equity, 2 Yr. CAGR % | 5.44 | 7.12 | 5.97 | 5.83 | 5.53 | |||||
Cash From Operations, 2 Yr. CAGR % | 14.88 | 71.91 | -67.3 | -59.37 | 151.73 | |||||
Capital Expenditures, 2 Yr. CAGR % | -14.9 | 14.14 | 44.87 | 33.82 | -20.54 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 8.24 | -23.01 | 117.72 | 179.4 | -60.32 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 19.34 | -14.73 | 102.45 | 157.2 | -53.85 | |||||
Dividend Per Share, 2 Yr. CAGR % | 64.94 | 56.34 | -8.98 | -6.97 | -0.96 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 16.54 | 15.5 | 15.79 | 13.77 | 5.31 | |||||
Gross Profit, 3 Yr. CAGR % | 12.11 | 7.5 | 10 | 4.34 | 0.98 | |||||
EBITDA, 3 Yr. CAGR % | 10.37 | 11.03 | 10.69 | 12.56 | 5.38 | |||||
EBITA, 3 Yr. CAGR % | 7.77 | 9.34 | 8.61 | 13.09 | 5.4 | |||||
EBIT, 3 Yr. CAGR % | 7.31 | 9.25 | 8.9 | 13.28 | 5.22 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 4.66 | 6.49 | 17.74 | 9.33 | -4.17 | |||||
Net Income, 3 Yr. CAGR % | 1.41 | 5.98 | 20.21 | 6.59 | -5.85 | |||||
Normalized Net Income, 3 Yr. CAGR % | -1.16 | 9.25 | -13.39 | 5.92 | 10.18 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -3.09 | 5.98 | 20.21 | 6.59 | -5.85 | |||||
Accounts Receivable, 3 Yr. CAGR % | 18.15 | 17.28 | 18.05 | 20.45 | 11.55 | |||||
Inventory, 3 Yr. CAGR % | 27.03 | 19.04 | 17.85 | 3.18 | 19.18 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 23.32 | 12.39 | 17.67 | 19.87 | 16.47 | |||||
Total Assets, 3 Yr. CAGR % | 14.91 | 9.73 | 12.82 | 12.13 | 10.06 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.89 | 5.82 | 5.95 | 4.98 | 3.22 | |||||
Common Equity, 3 Yr. CAGR % | 6.07 | 5.9 | 6.45 | 6.2 | 5.36 | |||||
Cash From Operations, 3 Yr. CAGR % | 11.33 | 12.75 | -33.73 | -43.6 | -14.56 | |||||
Capital Expenditures, 3 Yr. CAGR % | -17.11 | -3.31 | 29.86 | 34.13 | -0.56 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -18.77 | 2.67 | 44.89 | 86.7 | -3.62 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -15.17 | 9.74 | 47.54 | 77.89 | 0.85 | |||||
Dividend Per Share, 3 Yr. CAGR % | 11.5 | 46.94 | 20.2 | 0.31 | -11.34 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.83 | 18.13 | 15.35 | 13.68 | 10.96 | |||||
Gross Profit, 5 Yr. CAGR % | 13.82 | 13.27 | 8.64 | 5.41 | 6.72 | |||||
EBITDA, 5 Yr. CAGR % | 10.39 | 12.79 | 7.73 | 10.79 | 11.52 | |||||
EBITA, 5 Yr. CAGR % | 9.09 | 11.41 | 4.79 | 10.09 | 11.71 | |||||
EBIT, 5 Yr. CAGR % | 8.81 | 11.27 | 4.52 | 10.02 | 11.92 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.15 | 9.67 | 5.74 | 7.07 | 6.92 | |||||
Net Income, 5 Yr. CAGR % | 5.08 | 7.6 | 2.88 | 4.33 | 8.92 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.02 | 7.95 | -15.48 | 3.34 | 20.68 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -4.34 | 0.91 | 0.11 | 4.33 | 8.92 | |||||
Accounts Receivable, 5 Yr. CAGR % | 18.59 | 18.55 | 17.65 | 17.89 | 15.6 | |||||
Inventory, 5 Yr. CAGR % | 31.99 | 28.3 | 21.17 | 12.88 | 17.1 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 32.83 | 29.79 | 21.87 | 16.85 | 16.01 | |||||
Total Assets, 5 Yr. CAGR % | 23.93 | 20 | 13.83 | 10.8 | 11.34 | |||||
Tangible Book Value, 5 Yr. CAGR % | 34.35 | 18.47 | 5 | 5 | 4.92 | |||||
Common Equity, 5 Yr. CAGR % | 35.13 | 19.03 | 6.03 | 5.89 | 6.08 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.66 | 14.95 | -31.8 | -25.04 | 13.02 | |||||
Capital Expenditures, 5 Yr. CAGR % | 27.7 | 16.81 | 3.63 | 11.81 | 6.69 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 7.44 | -2.85 | 20.5 | 50.12 | -13.69 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 8.66 | -0.82 | 20.13 | 51.64 | -7.32 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | 2.81 | 22.39 | 11.24 |
Select your edition
All financial news and data tailored to specific country editions
















